Taylor Caldwell


Taylor Caldwell began his career at KPMG and quickly progressed to management roles with two specialty pharmaceuticals companies, Slate Pharmaceuticals and Novan Therapeutics, and a life sciences venture capital fund, Pappas Ventures.


He has raised over $100 million in numerous debt and equity offerings, including a successful $45 million IPO, over $10 million in federal contract and grant proceeds, and over $250 million in deal proceeds.


Taylor is a CPA and has Bachelor of Arts and Master’s in Accounting degrees from the University of North Carolina at Chapel Hill.